Industry News
Nanoplastics can reduce effectiveness of antibiotics
Using complex computer models, researchers were able to prove that nanoplastic particles can bind the antibiotic known as tetracycline and thus impair its effectiveness. [ + ]
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping ability. There is also a risk that these patients will become depressed by the treatment. [ + ]
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing female scientists from ANZ, while ATSE has announced 250+ scholarships as part of its Elevate: Boosting diversity in STEM program. [ + ]
CRISPR molecular scissors can introduce genetic defects
CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases, but they can also lead to new defects when it comes to chronic granulomatous disease. [ + ]
FDA approves new treatment for graft-versus-host disease
Back in 2014, Dr Kelli MacDonald's lab at QIMR Berghofer identified the cellular process causing chronic GVHD as well as the antibody that could block this process. [ + ]
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in neurodegenerative disease, particularly MND and frontotemporal dementia. [ + ]
High-potency cannabis use leaves a unique mark on DNA
Frequent users of high-potency cannabis have changes in genes related to mitochondrial and immune function — particularly the CAVIN1 gene, which could affect energy and immune response. [ + ]
Flinders facility to use the micro realm to understand the past
AusMAP aims to revolutionise the ways scientists address key questions and grand challenges in the fields of archaeology, palaeontology and the geosciences. [ + ]
Scaffold-based method for culturing antitumour bacteria
Bacteria-based cancer therapy represents an exciting new treatment option — but in order to fully harness this approach, a safe and efficient method for producing natural anticancer bacteria is needed. [ + ]
ACCC concerned by Blackstone's proposed acquisition of I'rom
The ACCC is concerned that the proposed acquisition would likely have the effect of substantially lessening competition in the supply of phase 1 clinical trials in Australia. [ + ]
mpox vaccine appears safe and effective in adolescents
Interim analysis of an mpox vaccine trial has found the vaccine is safe in adolescents and generates an antibody response equivalent to that seen in adults. [ + ]
Cancer drug eliminates bone metastasis in lab models
Researchers have developed a novel treatment that is specific to breast cancer bone metastasis and can successfully work in the bone microenvironment, which is often resistant to therapeutics. [ + ]
A new, simpler method for detecting PFAS in water
Researchers demonstrated that their small, inexpensive device is feasible for identifying various PFAS families and detecting PFAS at levels as low as 400 ppt. [ + ]
TGA rejects Alzheimer's drug due to safety concerns
The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did not outweigh the safety risks associated with its use. [ + ]
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with doubled risk of pre-eclampsia in women who become pregnant by IVF. [ + ]